SUNNYVALE, Calif., Sept. 2, 2025 /PRNewswire/ -- Inflammatix, a pioneering host response diagnostics company, today announced the publication of analytical data in the Journal of Clinical Microbiology ...

Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to endocrine therapy alone In the seven-year ...

Armed with new survival data from the monarchE trial of CDK4/6 inhibitor Verzenio, Eli Lilly looks set to cement the drug's place in the treatment of early-stage breast cancer, and keep its nose in ...

Global growth is projected to decline after a period of steady but underwhelming performance, amid policy shifts and new uncertainties. Global headline inflation is expected to decline further, ...

Getting the most out of A/B and other controlled tests by Ron Kohavi and Stefan Thomke In 2012 a Microsoft employee working on Bing had an idea about changing the way the search engine displayed ad ...